首页> 外文OA文献 >Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations
【2h】

Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations

机译:对980例疑似遗传性视神经病变进行分子筛查,并报道了77种新的Opa1突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report the results of molecular screening in 980 patients carried out as part of their work-up for suspected hereditary optic neuropathies. All the patients were investigated for Leberu27s hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (ADOA), by searching for the ten primary LHON-causing mtDNA mutations and examining the entire coding sequences of the OPA1 and OPA3 genes, the two genes currently identified in ADOA. Molecular defects were identified in 440 patients (45% of screened patients). Among these, 295 patients (67%) had an OPA1 mutation, 131 patients (30%) had an mtDNA mutation, and 14 patients (3%), belonging to three unrelated families, had an OPA3 mutation. Interestingly, OPA1 mutations were found in 157 (40%) of the 392 apparently sporadic cases of optic atrophy. The eOPA1 locus-specific database now contains a total of 204 OPA1 mutations, including 77 novel OPA1 mutations reported here. The statistical analysis of this large set of mutations has led us to propose a diagnostic strategy that should help with the molecular work-up of optic neuropathies. Our results highlight the importance of investigating LHON-causing mtDNA mutations as well as OPA1 and OPA3 mutations in cases of suspected hereditary optic neuropathy, even in absence of a family history of the disease. © 2009 Wiley-Liss, Inc.
机译:我们报告了980名患者的分子筛查结果,这是他们对可疑的遗传性视神经病变进行检查的一部分。通过寻找十个引起LHON的主要mtDNA突变并检查OPA1和OPA3基因的完整编码序列,对所有患者进行了Leber遗传性视神经病变(LHON)和常染色体显性视神经萎缩(ADOA)的研究。目前在ADOA中鉴定的基因。在440名患者中发现了分子缺陷(占筛查患者的45%)。其中,295例患者(67%)发生了OPA1突变,131例患者(30%)发生了mtDNA突变,14例患者(3%)属于三个无关家族,发生了OPA3突变。有趣的是,在392例偶发性视神经萎缩病例中,有157例(占40%)发现了OPA1突变。现在,eOPA1基因座特异性数据库包含总共204个OPA1突变,包括此处报道的77个新的OPA1突变。对大量突变的统计分析使我们提出了一种诊断策略,该方法应有助于对视神经病变进行分子检查。我们的结果强调了在怀疑遗传性视神经病变的情况下,即使在没有家族病史的情况下,调查引起LHON的mtDNA突变以及OPA1和OPA3突变的重要性。 ©2009 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号